| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 11/11/1993 | WO1993021944A1 Methods of treating cancer using modified c-reactive protein |
| 11/11/1993 | WO1993021940A1 Intraoperative, intravascular and endoscopic tumor and lesion detection and therapy |
| 11/11/1993 | CA2135059A1 Complexing agents and targeting immunoreagents |
| 11/11/1993 | CA2134772A1 Substituted 1 , 1, 2 - triphenylbutenes and their use in the treatment and diagnosis of cancer |
| 11/11/1993 | CA2134675A1 Development of a vector to target gene expression to the epidermis of transcenic animals |
| 11/11/1993 | CA2133746A1 Phosphorylated contrast agents for mri of the gi tract |
| 11/11/1993 | CA2133580A1 Intraoperative, intravascular and endoscopic tumor and lesion detection and therapy |
| 11/10/1993 | EP0569113A1 Liposome compositions of porphyrin photosensitizers |
| 11/10/1993 | CA2095780A1 Agent and process for treating body fluids in the determination of neopterin |
| 11/09/1993 | US5260478 Contrast agents in x-ray imaging compositions; medical diagnosis |
| 11/09/1993 | US5260313 Diagnosis and treatment of various neuralgias |
| 11/09/1993 | US5260050 Methods and compositions for magnetic resonance imaging comprising superparamagnetic ferromagnetically coupled chromium complexes |
| 11/09/1993 | US5260049 Iodophenolic ether |
| 11/09/1993 | CA1324150C Paramagnetic chelates useful for nmr imaging |
| 11/09/1993 | CA1324080C Bioadhesion drug carriers for endothelial and epithelial uptake and lesional localization of therapeutic and diagnostic agents |
| 11/03/1993 | EP0568156A1 X-ray contrast formulations and method for their use in the visualization of the GI tract |
| 11/03/1993 | EP0568155A1 X-ray contrast formulations containing film-forming materials |
| 11/03/1993 | EP0567514A1 A METHOD AND A SYSTEM FOR ENHANCED $i(IN VIVO) CLEARANCE OF DIAGNOSTIC AND/OR THERAPEUTIC AGENTS BY EXTRACORPOREAL DEPLETION, AND THE USE OF SAID AGENTS FOR SAID PURPOSE |
| 11/03/1993 | EP0305497B1 Fertility prediction by use of clomiphene challenge test |
| 11/02/1993 | US5258313 Process for the detection or determination of oxygen by EPR spectrometry using radical lithium phthalocyanines and composition usable for in vivo determination |
| 11/02/1993 | US5258172 Iodinated aliphatic emulsions for X-ray contrast |
| 11/02/1993 | CA2094893A1 X-ray contrast compositions containing film-forming materials |
| 11/02/1993 | CA2093083A1 X-ray contrast compositions and method for their use in the visualization of the gi tract |
| 10/28/1993 | WO1993021226A1 Cartilage matrix protein and methods for use |
| 10/28/1993 | WO1993021195A1 Water-soluble retinoids |
| 10/28/1993 | WO1993020851A1 Methods for identifying agents useful in treating septicemia |
| 10/28/1993 | WO1993020802A1 Acoustically reflective liposomes and methods to make and use the same |
| 10/28/1993 | WO1993020800A1 Composition for therapeutic or diagnostic use, process for its preparation and its use |
| 10/28/1993 | CA2117780A1 Cartillage matrix protein and methods for use |
| 10/28/1993 | CA2117749A1 Composition for therapeutic or diagnostic use, process for its preparation and its use |
| 10/27/1993 | EP0566601A1 Echo contrast agent. |
| 10/26/1993 | US5256532 Methods, reagents and test kits for determination of subpopulations of biological entities |
| 10/26/1993 | US5256406 Treatment of hair loss and dermatological problems |
| 10/26/1993 | US5256397 2,2,5,5-tetrasubstituted-pyrrolidine-1-oxyl compounds useful as MRI agents |
| 10/26/1993 | US5256394 Radiological imaging method, and contrast media reagents therefor |
| 10/26/1993 | CA1323563C2 Lymphographic imaging method and kit |
| 10/21/1993 | DE4308668A1 Contrast agent for ultrasound diagnoses - consists of aq. medium contg. gas filled particles coated with a layer of magnetic ferrite |
| 10/20/1993 | EP0565930A1 Tetraazacyclododecane tetraacetic acid derivatives and the use thereof as diagnostic agents |
| 10/20/1993 | EP0565668A1 Biological stain composition, method of preparation and method of use for delineation of epitheleal cancer |
| 10/19/1993 | US5254329 Method for improving visualization of serotonergic structures in nonhuman vertebrates |
| 10/19/1993 | CA1323299C Contrast agent for nmr scanning |
| 10/14/1993 | WO1993020439A1 Compositions and methods for regulating cellular signal transducing systems |
| 10/14/1993 | WO1993019788A1 Methods and compositions for magnetic resonance imaging |
| 10/14/1993 | WO1993019782A1 Specific detection of cell surface receptor leukocyte adhesion molecule-1 |
| 10/14/1993 | WO1993019668A1 Method and kit for imaging and treating organs and tissues |
| 10/14/1993 | WO1993019605A1 Evaluation and treatment of patients with progressive immunosuppression |
| 10/14/1993 | WO1993013808A3 Improvements in or relating to contrast agents |
| 10/14/1993 | CA2132744A1 Methods and compositions for magnetic resonance imaging |
| 10/14/1993 | CA2132624A1 Compositions and methods for regulating cellular signal transducing systems |
| 10/13/1993 | EP0564495A1 Tissue factor based prothrombin time reagent |
| 10/13/1993 | EP0458886B1 Agents for diagnosing and treating melanomas, aromatic halogenated derivatives usable as such agents and their preparation |
| 10/13/1993 | EP0414700B1 Contrast agents for magnetic resonance imaging |
| 10/13/1993 | EP0353267B1 Emulsion for parenteral administration |
| 10/13/1993 | CN1022411C Process for preparing ligands nitrogenous cycle |
| 10/12/1993 | US5252720 Metal complexes of water soluble texaphyrins |
| 10/12/1993 | US5252317 Amplifier molecules for diagnosis and therapy derived from 3,5-bis[1-(3-amino-2,2-bis (aminomethyl)-propyl) oxymethyl] benzoic acid |
| 10/06/1993 | EP0563179A1 Vascular catheter having low-profile distal end. |
| 10/06/1993 | EP0563145A1 Chelating agents |
| 10/05/1993 | US5250672 A polysaccharide which is chemically linked both to a nitroxyl spin compound and an organic complexing agent to which is complexed a paramagnetic metal ion |
| 10/05/1993 | US5250285 Hydroxy-aryl metal chelates for diagnostic NMR imaging |
| 10/05/1993 | US5250283 Organic contrast agent analog and method of making same |
| 09/30/1993 | WO1993019366A1 Fluorescence immunoassays using fluorescent dyes free of aggregation and serum binding |
| 09/30/1993 | WO1993019179A1 Ifn receptors recognition factors, protein sequences and methods of use thereof |
| 09/30/1993 | WO1993019166A1 Small animal model for studying cholesterol metabolism |
| 09/30/1993 | WO1993018797A1 Method of intraoperatively detecting and locating tumoral tissues |
| 09/30/1993 | WO1993018796A1 Reagent for nuclear magnetic resonance |
| 09/30/1993 | WO1993018795A1 Mri contrast medium and diagnostic method |
| 09/30/1993 | WO1993016185A3 Biosynthetic binding protein for cancer marker |
| 09/30/1993 | DE4305660A1 Controlling size distribution of gas or liquid bubbles - by coupling ultrasound field to the liquid medium which contains the bubbles and using sound frequency and energy chosen to break the bubbles up into smaller bubbles |
| 09/30/1993 | DE4209488A1 Ectogenic particles with smooth surface and/or concave segments |
| 09/30/1993 | CA2132317A1 Ifn receptors recognition factors, protein sequences and methods of use thereof |
| 09/30/1993 | CA2131315A1 Method of intraoperatively detecting and locating tumoral tissues |
| 09/29/1993 | EP0562508A2 Protein with bone formation ability and process for its production |
| 09/29/1993 | EP0562119A1 Medicated syringe preparation |
| 09/29/1993 | EP0562026A1 Balanced pressure solid fuel heating unit |
| 09/29/1993 | CN1076604A Radiological imaging method |
| 09/28/1993 | US5248498 Cluster compounds |
| 09/28/1993 | US5248492 Low molecular weight carbohydrates as additives to stabilize metal oxide compositions |
| 09/28/1993 | CA2092768A1 Protein with bone formation ability and process for its production |
| 09/28/1993 | CA2092596A1 Tetraazacyclododecane derivative and its use |
| 09/22/1993 | EP0561140A1 Methods for pharmacokinetical studies of insulin expression involving transgenic mammal |
| 09/22/1993 | EP0560947A1 Tri- and tetra-valent monospecific antigen-binding proteins |
| 09/21/1993 | US5246696 Medical diagnosis with manganese or gadolinium complex with hydroxy trimethylene dinitrilo tetraacetic acid |
| 09/21/1993 | CA1322341C Method for the preparation of antibody-fragment conjugates |
| 09/20/1993 | CA2091796A1 Contrast medium for ultrasonic diagnosis |
| 09/17/1993 | EP0571593A4 New non ionic iodized agents for x-ray contrasting, method for preparing them and galenical compositions containing them. |
| 09/16/1993 | WO1993018160A1 Anti-viral fusion peptides |
| 09/16/1993 | WO1993018144A1 Recombination activating gene deficient animal |
| 09/16/1993 | WO1993018070A1 Chemical compounds |
| 09/16/1993 | WO1993017718A1 Improvements in or relating to contrast agents |
| 09/16/1993 | WO1993017715A1 Diagnostic and/or therapeutic agents, targeted to neovascular endothelial cells |
| 09/16/1993 | WO1993017714A1 Conjugates of biotin and deferoxamine for radioimmunoimaging and radioimmunotherapy |
| 09/16/1993 | WO1993017695A1 Diagnosis and treatment of various neuralgias |
| 09/16/1993 | WO1993017665A1 Methods and apparatus for drug delivery using supercritical solutions |
| 09/16/1993 | CA2452130A1 Methods and compositions for targeting the vasculature of solid tumors |
| 09/16/1993 | CA2131382A1 Conjugates of biotin and deferoxamine for radioimmunoimaging and radioimmunotherapy |
| 09/15/1993 | EP0559738A1 Methods for detection and quantitation of cell subsets within subpopulations of a mixed cell population |
| 09/15/1993 | EP0401377B1 Iron-containing preparation for use as nmr contrast medium |
| 09/14/1993 | CA1322156C Metal complex-containing pharmaceutical agents |
| 09/12/1993 | WO1993024632A1 Hybrid siv/hiv-1 viral vectors and monkey model for aids |